FOXO 0.16 FOXO Technologies Inc.
| Range: | 0.13-1.02 | Vol Avg: | 226823 | Last Div: | 0 | Changes: | 0 |
| Beta: | 2.01 | Cap: | 0.00B | Currency: | USD | Exchange: | AMEX |
| Sector: | Healthcare | IPO: | Fri Sep 16 2022 | Empoloyees: | 4 | ||
| CUSIP: | CIK: | 0001812360 | ISIN: | US3514713052 | Country: | US | |
| CEO: | Mr. Mark Brian White | Website: | https://www.foxotechnologies.com | ||||
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow